United States
Stanford University - Division of Gastroenterology and Hepatology
epidemiology; natural history; obesity; non-alcoholic fatty liver; metabolic syndrome
Hepatitis B virus; Population-based; Diagnosis; Treatment; Real-world
hepatitis B, vaccination, immunity, HBV
Epidemiology, fatty liver, forecast, GBD, metabolic, NAFLD, sex disparities, MASLD
Primary Liver Cancer, Global Burden of Disease Study, Etiology, Prediction, Incidence, Mortality, Disability-Adjusted Life Years, Hepatocellular Carcinoma
Keywords: liver cancer, prevention, incidence, hepatoma
hepatitis B, indeterminate phase, hepatocellular carcinoma, treatment criteria
fatty liver, Magnetic resonance imaging, Ultrasound
Epidemiology, Natural history, Population-based, Risk factors, Diabetes, Sex, Age, Cirrhosis, Subgroup, Cohort study
epidemiology, NAFLD, HBV, HBV, HCV, HCV, children and adolescents, children and adolescents
Treatment evaluation; Treatment eligibility; Treatment rate; Treatment eligible; Linkage to care; Connection to care
Hepatocellular carcinoma, cirrhosis, liver-related mortality, major adverse liver outcomes, social determinants of health